CorMedix Inc [CRMD] stock prices are down -1.00% to $10.86 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CRMD shares have gain 4.62% over the last week, with a monthly amount drifted -2.82%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CorMedix Inc [NASDAQ: CRMD] stock has seen the most recent analyst activity on March 07, 2025, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $18. Previously, D. Boral Capital started tracking the stock with Buy rating on January 13, 2025, and set its price target to $15. On August 26, 2024, Rodman & Renshaw initiated with a Buy rating and assigned a price target of $13 on the stock. RBC Capital Mkts started tracking the stock assigning a Outperform rating and suggested a price target of $6 on August 10, 2023. Needham initiated its recommendation with a Buy and recommended $31 as its price target on February 17, 2021. JMP Securities started tracking with a Mkt Outperform rating for this stock on September 29, 2020, and assigned it a price target of $22. In a note dated September 21, 2020, Truist initiated an Buy rating and provided a target price of $20 on this stock.
The stock price of CorMedix Inc [CRMD] has been fluctuating between $3.61 and $13.85 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. CorMedix Inc [NASDAQ: CRMD] shares were valued at $10.86 at the most recent close of the market. An investor can expect a potential drop of -17.13% based on the average CRMD price forecast.
Analyzing the CRMD fundamentals
Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -4.06%, Pretax Profit Margin comes in at -3.78%, and Net Profit Margin reading is -3.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.59, Equity is -0.79 and Total Capital is -0.86. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.49 points at the first support level, and at 10.11 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.28, and for the 2nd resistance point, it is at 11.69.
Ratios To Look Out For
It’s worth pointing out that CorMedix Inc [NASDAQ:CRMD]’s Current Ratio is 3.96. As well, the Quick Ratio is 3.60, while the Cash Ratio is 1.91. Considering the valuation of this stock, the price to sales ratio is 53.75, the price to book ratio is 10.71.
Transactions by insiders
Recent insider trading involved Mistry Erin, EVP, Chief Commercial Officer, that happened on Oct 31 ’24 when 1500.0 shares were purchased. EVP, Hurlburt Elizabeth completed a deal on Nov 14 ’24 to sell 0.14 million shares. Meanwhile, Officer Hurlburt Elizabeth bought 0.14 million shares on Nov 14 ’24.
